Last reviewed · How we verify
Volume-Stable Collagen Matrix — Competitive Intelligence Brief
phase 3
Wound Healing
Biologic
Live · refreshed every 30 min
Target snapshot
Volume-Stable Collagen Matrix (Volume-Stable Collagen Matrix) — Bulent Ecevit University. Volume-Stable Collagen Matrix is a biocompatible scaffold that supports tissue regeneration.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Volume-Stable Collagen Matrix TARGET | Volume-Stable Collagen Matrix | Bulent Ecevit University | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Volume-Stable Collagen Matrix CI watch — RSS
- Volume-Stable Collagen Matrix CI watch — Atom
- Volume-Stable Collagen Matrix CI watch — JSON
- Volume-Stable Collagen Matrix alone — RSS
Cite this brief
Drug Landscape (2026). Volume-Stable Collagen Matrix — Competitive Intelligence Brief. https://druglandscape.com/ci/volume-stable-collagen-matrix. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab